Mostrar el registro sencillo del ítem

Artículo

dc.creatorCauce, Alejandroes
dc.creatorBriales, Alejandraes
dc.creatorRodríguez Rojas, Alexandroes
dc.creatorCostas, Colomaes
dc.creatorPascual Hernández, Álvaroes
dc.creatorBlázquez, Jesúses
dc.date.accessioned2017-07-27T11:37:43Z
dc.date.available2017-07-27T11:37:43Z
dc.date.issued2012-05-01
dc.identifier.citationCauce, A., Briales, A., Rodríguez Rojas, A., Costas, C., Pascual Hernández, Á. y Blázquez, J. (2012). Genomewide overexpression screen for fosfomycin resistance in Escherichia coli: Mura confers clinical resistance at low fitness cost. Antimicrobial Agents and Chemotherapy, 56 (5), 2767-2769.
dc.identifier.issn0066-4804 (impreso)es
dc.identifier.issn1098-6596 (electrónico)es
dc.identifier.urihttp://hdl.handle.net/11441/63338
dc.description.abstractTo determine whether the overexpression of chromosomal genes can confer fosfomycin resistance, genomewide screening of a complete set of 5,272 plasmid-expressed open reading frames of Escherichia coli (ASKA collection) was performed. Major results are that (i) no clinical level of resistance is achieved by overexpressing chromosomal genes, except murA; (ii) this level is reached at a low fitness cost; and (iii) this cost is much lower than that imposed by other mutations conferring fosfomycin resistance.es
dc.description.sponsorshipMinisterio de Ciencia e Innovación y Instituto de Salud Carlos III PI10/00105es
dc.description.sponsorshipSpanish Network for Research on Infectious Diseases REIPI RD06/0008es
dc.formatapplication/pdfes
dc.language.isoenges
dc.publisherAmerican Society for Microbiologyes
dc.relation.ispartofAntimicrobial Agents and Chemotherapy, 56 (5), 2767-2769.
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.titleGenomewide overexpression screen for fosfomycin resistance in Escherichia coli: Mura confers clinical resistance at low fitness costes
dc.typeinfo:eu-repo/semantics/articlees
dcterms.identifierhttps://ror.org/03yxnpp24
dc.type.versioninfo:eu-repo/semantics/publishedVersiones
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses
dc.contributor.affiliationUniversidad de Sevilla. Departamento de Microbiologíaes
dc.relation.projectIDPI10/00105es
dc.relation.projectIDREIPI RD06/0008es
dc.relation.publisherversionhttp://dx.doi.org/10.1128/AAC.06122-11es
dc.identifier.doi10.1128/AAC.06122-11es
idus.format.extent3 p.es
dc.journaltitleAntimicrobial Agents and Chemotherapyes
dc.publication.volumen56es
dc.publication.issue5es
dc.publication.initialPage2767es
dc.publication.endPage2769es
dc.contributor.funderMinisterio de Ciencia e Innovación (MICIN). España

FicherosTamañoFormatoVerDescripción
Genomewide overexpression screen ...290.0KbIcon   [PDF] Ver/Abrir  

Este registro aparece en las siguientes colecciones

Mostrar el registro sencillo del ítem

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
Excepto si se señala otra cosa, la licencia del ítem se describe como: Attribution-NonCommercial-NoDerivatives 4.0 Internacional